Wellington Partners

Dr Thomas Widmann and Prof Dr Erich Schlick have been appointed as general partners at Wellington Partners, with a view to strengthening its life sciences activities. Widmann has been a venture partner of the Wellington Life Science team for the past two years and served as chairman of Wellington Partner's portfolio company Immatics, in Germany. In the 1980s he formed his first company in San Diego, before heading up global development for cardiovascular products at Roche. In 1996 he formed clinical research organisation Hesperion, and as the first CEO of Actelion, one of Europe's leading biotech companies, he won Wellington Partners and others as investors.Schlick, who also joins as a general partner, served as director of 3i Germany's healthcare division, and prior to that was part of the senior management team at BASF Pharma for 10 years.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare